Common use of Ownership of Joint Technology Clause in Contracts

Ownership of Joint Technology. Subject to Section 5.1.2 and the license grants under Article 3, the Parties shall each own an equal, undivided interest in any and all (a) Information and Inventions, conceived, discovered, developed or otherwise made, as necessary to establish authorship, inventorship or ownership under Applicable Law, jointly by or on behalf of Medarex (or its Affiliates or, to the extent permitted, its sublicensees), on the one hand, and Northwest (or its Affiliates or, to the extent permitted, its sublicensees), on the other hand, in connection with the work conducted under or in connection with this Agreement, whether or not patented or patentable, but excluding any Mice Materials or Mice-Related Technology, and (b) patents (including (x) all patents and patent applications, (y) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, reexaminations, extensions, supplementary protection certificates and the like, and any provisional applications, of any such patents or patent applications, and (z) any foreign or international equivalent of any of the foregoing) (the, "JOINT PATENTS") and other intellectual property rights with respect thereto (collectively, the "JOINT TECHNOLOGY"), provided, however, that, except as otherwise expressly provided herein, neither a Party nor any of its Affiliates, licensees or sublicensees shall, directly or indirectly, Exploit any

Ownership of Joint Technology. Subject to Section 5.1.2 and the license grants under Article 32, deCODE and at least one of Medarex and Genmab (the Parties "JOINT INVENTORS") shall each own an equal, undivided interest in any and all (ai) Information and Inventions, conceived, discovered, developed or otherwise made, as necessary to establish authorship, inventorship or ownership under Applicable Law, jointly by or on behalf of Medarex such Joint Inventors (or or, with respect to each Joint Inventor, its Affiliates or, to the extent permitted, its sublicensees), on the one hand, and Northwest (or its Affiliates or, to the extent permitted, its sublicensees), on the other hand, in connection with the work conducted under or in connection with this Agreement, whether or not patented or patentable, but excluding any Mice Materials or Mice-Related Technology, ; and (bii) patents Patents (including (x) all patents and patent applications, (y) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, reexaminations, extensions, supplementary protection certificates and the like, and any provisional applications, of any such patents or patent applications, and (z) any foreign or international equivalent of any of the foregoing) (the, "JOINT PATENTS") and other intellectual property rights with respect thereto (collectively, the "JOINT TECHNOLOGY"), ; provided, however, that, except as otherwise expressly provided herein, that neither a Party Joint Inventor nor any of its Affiliates, licensees or sublicensees shall, directly or indirectly, Exploit anyany Joint Technology or other such intellectual property rights without the consent of the other Joint Inventor(s), not to be unreasonably withheld or delayed, except that each Party shall have the right to Exploit such Joint Technology for internal research and discovery purposes (as opposed to the development, commercialization or other Exploitation of products or technology resulting therefrom) without the consent of the other Party; provided, however, that neither Party shall have the right to use Antibodies with respect to the Unilateral Targets except as set forth hereunder. Each Joint Inventor shall promptly disclose to the other Joint Inventor(s) in writing, and shall cause its Affiliates, licensees and sublicensees to so disclose, the development, making, conception or reduction to practice of any Joint Technology.

Ownership of Joint Technology. Subject to Section 5.1.2 and the license grants under Article 32, deCODE and at least one of Medarex and Genmab (the Parties "JOINT INVENTORS") shall each own an equal, undivided interest in any and all (ai) Information and Inventions, conceived, discovered, developed or otherwise made, as necessary to establish authorship, inventorship or ownership under Applicable Law, jointly by or on behalf of Medarex such Joint Inventors (or or, with respect to each Joint Inventor, its Affiliates or, to the extent permitted, its sublicensees), on the one hand, and Northwest (or its Affiliates or, to the extent permitted, its sublicensees), on the other hand, in connection with the work conducted under or in connection with this Agreement, whether or not patented or patentable, but excluding any Mice Materials or Mice-Related Technology, ; and (bii) patents Patents (including (x) all patents and patent applications, (y) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, reexaminations, extensions, supplementary protection certificates and the like, and any provisional applications, of any such patents or patent applications, and (z) any foreign or international equivalent of any of the foregoing) (the, "JOINT PATENTS") and other intellectual property rights with respect thereto (collectively, the "JOINT TECHNOLOGY"), ; provided, however, that, except as otherwise expressly provided herein, that neither a Party Joint Inventor nor any of its Affiliates, licensees or sublicensees shall, directly or indirectly, Exploit anyany Joint Technology or other such intellectual property rights without the consent of the other Joint Inventor(s), not to be unreasonably withheld or delayed, except that each Party shall have the right to Exploit such Joint Technology for internal research and discovery purposes (as opposed to the development, commercialization or other Exploitation of products or technology resulting therefrom) without the consent of the other Party; provided, however, that neither Party shall have the right to use Antibodies

Ownership of Joint Technology. Subject to Section 5.1.2 and the license grants under Article 3, the Parties shall each own an equal, undivided interest in any and all (a) Information and Inventions, conceived, discovered, developed or otherwise made, as necessary to establish authorship, inventorship or ownership under Applicable Law, jointly by or on behalf of Medarex Northwest (or its Affiliates or, to the extent permitted, its sublicensees), on the one hand, and Northwest Medarex (or its Affiliates or, to the extent permitted, its sublicensees), on the other hand, in connection with the work conducted under or in connection with this Agreement, whether or not patented or patentable, but excluding any Mice Materials or Mice-Related Technology, and (b) patents (including (x) all patents and patent applications, (y) any substitutions, divisions, continuations, continuations-in-part, reissues, renewals, registrations, confirmations, reexaminations, extensions, supplementary protection certificates and the like, and any provisional applications, of any such patents or patent applications, and (z) any foreign or international equivalent of any of the foregoing) (the, "JOINT PATENTS") and other intellectual property rights with respect thereto (collectively, the "JOINT TECHNOLOGY"), ; provided, however, that, except as otherwise expressly provided herein, neither a Party nor any of its Affiliates, licensees or sublicensees shall, directly or indirectly, Exploit anyany Joint Technology or other such intellectual property rights without the consent of the other Party, not to be unreasonably withheld or delayed. Each Party shall promptly disclose to the other Party in writing, and shall cause its Affiliates, licensees and sublicensees to so disclose, the development, making, conception or reduction to practice of any Joint Technology.